AYTU BioPharma
AYTU
8 hedge funds and large institutions have $8.23M invested in AYTU BioPharma in 2019 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 6 closing their positions.
18% more capital invested
Capital invested by funds: $6.96M → $8.23M (+$1.26M)
0.04% more ownership
Funds ownership: 0.16% → 0.2% (+0.04%)
33% less funds holding
Funds holding: 12 → 8 (-4)
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$2.72M |
| 2 |
Morgan Stanley
New York
|
+$38.2K |
| 3 |
SC
Searle & Co
Greenwich,
Connecticut
|
+$21.7K |
| 4 |
BlackRock
New York
|
+$4.42K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$3.07K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WC
Wexford Capital
West Palm Beach,
Florida
|
-$123K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$58K |
| 3 |
VF
Virtu Financial
New York
|
-$36K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$15K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $7.73M | +$2.72M | +14,150 | +55% |
|
|
SC
2
Searle & Co
Greenwich,
Connecticut
| $265K | +$21.7K | +113 | +9% |
|
3
Vanguard Group
Malvern,
Pennsylvania
| $93K | – | – | – |
|
4
Geode Capital Management
Boston,
Massachusetts
| $63K | – | – | – |
|
|
5
Morgan Stanley
New York
| $39K | +$38.2K | +199 | New |
|
|
6
BlackRock
New York
| $22K | +$4.42K | +23 | +26% |
|
7
Northern Trust
Chicago,
Illinois
| $10K | – | – | – |
|
|
8
UBS Group
Zurich,
Switzerland
| $3K | +$3.07K | +16 | New |
|
|
WC
9
Wexford Capital
West Palm Beach,
Florida
| – | -$123K | -509 | Closed |
|
|
10
Acadian Asset Management
Boston,
Massachusetts
| – | -$58K | -243 | Closed |
|
|
VF
11
Virtu Financial
New York
| – | -$36K | -149 | Closed |
|
|
12
Citadel Advisors
Miami,
Florida
| – | -$15K | -64 | Closed |
|
|
13
Victory Capital Management
San Antonio,
Texas
| – | -$4K | -15 | Closed |
|
AYTU Hedge Fund Activity: Q4 2019 in Review
8 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in AYTU BioPharma (AYTU) for Q4 2019, worth a combined $8.23M — up 18% from $6.96M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of AYTU and 2 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 3 added.
The largest buyer was Armistice Capital, adding an estimated $2.72M. The largest seller was Wexford Capital, exiting entirely with an estimated $123K sold.
- 8 institutional investors held AYTU BioPharma (AYTU) as of Q4 2019, down from 12 in Q3 2019.
- Funds reported $8.23M of AYTU BioPharma stock for Q4 2019, up 18% quarter-over-quarter.
- 2 funds opened new AYTU BioPharma positions in Q4 2019 and 6 closed out, a net change of -4 holders.
- The largest AYTU BioPharma buyer in Q4 2019 was Armistice Capital, an estimated $2.72M added.
- The largest AYTU BioPharma seller in Q4 2019 was Wexford Capital, an estimated $123K sold.
Based on aggregated 13F filings for Q4 2019.